Table 6 Assessment of associations between proteins plasma membrane expression in CRC lymph node metastasis and clinical data

 Male

77

25 (32.5)

0.581

74

46 (62.2)

0.317

77

62 (91.9)

0.159

71

47 (76.7)

0.523^a

 Female

40

11 (27.5)

40

21 (52.5)

40

34 (82.4)

38

22 (86.4)

 ≤45

10

3 (30.0)

1.000^a

8

4 (50.0)

0.715^a

9

8 (75.0)

0.228^a

8

5 (40.0)

0.053^a

 >45

107

33 (30.8)

106

63 (59.4)

108

88 (89.8)

101

64 (82.8)

 Asymptomatic

19

6 (31.6)

0.933

18

8 (44.4)

0.178

22

18 (88.9)

1.000^a

16

10 (60.0)

0.109^a

 Symptomatic

98

30 (30.6)

96

59 (61.5)

95

78 (88.5)

93

59 (83.1)

 Colon

94

28 (29.8)

0.642

91

58 (63.7)

0.032

95

81 (88.9)

0.681^a

88

57 (80.7)

0.698^a

 Rectum

23

8 (34.8)

23

9 (39.1)

22

15 (86.7)

21

12 (75.0)

 Polypoid

47

14 (29.8)

0.596

47

27 (57.4)

0.534

45

36 (86.1)

0.701

45

25 (84.0)

0.500

 Ulcerative

31

7 (22.6)

30

20 (66.7)

34

28 (85.7)

28

20 (70.0)

 Infiltrative

13

5 (38.5)

13

6 (46.2)

12

11 (90.9)

11

6 (100.0)

 Exophytic

14

6 (42.9)

13

7 (53.8)

14

12 (100.0)

14

11 (81.8)

 Vilosous

1

0 (0.0)

1

0 (0.0)

1

1 (100.0)

1

1 (100.0)

 <5

71

21 (29.6)

0.354

67

42 (62.7)

0.434

68

56 (91.1)

0.120

65

40 (85.0)

0.237^a

 ≥5

25

5 (20.0)

26

14 (53.8)

26

23 (78.3)

23

13 (69.2)